The government announced the first ten drugs that are the subject of price negotiations between the U.S. government and private companies. For decades, the government has been prohibited from negotiating the price it pays through Medicare for medication — until the rule was relaxed under the Affordable Care Act.
This episode: White House correspondent Tamara Keith, White House reporter Deepa Shivaram, and Pharmaceuticals correspondent Sydney Lupkin.
The podcast is produced by Elena Moore and Casey Morell. Our editor is Eric McDaniel. Our executive producer is Muthoni Muturi.
Unlock access to this and other bonus content by supporting The NPR Politics Podcast+. Sign up via Apple Podcasts or at plus.npr.org. Connect:Email the show at
nprpolitics@npr.orgJoin the NPR Politics Podcast
Facebook Group.
Subscribe to the
NPR Politics Newsletter.
To manage podcast ad preferences, review the links below:
See
pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
Learn more about sponsor message choices:
podcastchoices.com/adchoicesNPR Privacy Policy